B O O K - American College of Rheumatology

ACR Poster Session A
83. Respiratory Cause Mortality Was Greater in 54 Incident
Rheumatoid Arthritis (RA) Patients Than 204 Community-
Based, Non-RA Matched Cohort Controls (CN). Alfonse T. Masi
and Jean C. Aldag, University of Illinois College of Medicine at
Peoria, Peoria, IL.
84. Rheumatoid Arthritis (RA) Is the Only One of 8 Diseases for
Which a Patient History and Physical Examination (Versus
Laboratory Tests and Ancillary Studies) Were Rated as Most
Important for Clinical Decisions by >50% in a Physician Survey.
Lauren McCollum 4 , Sangmo Park 4 , Tuulikki Sokka 2 , Hasan Yazici 1
and Theodore Pincus 3 , 1 Cerrahpasa Medical Faculty, Istanbul,
Turkey, 2 Jyvaskyla Central Hospital, Jyvaskyla, Finland, 3 New York
University Hospital for Joint Disease, Hastings-on-Hudson, NY,
4
NYU Hospital for Joint Diseases.
85. Similar Performance of New and Old Criteria for Rheumatoid
Arthritis in an Early Arthritis Cohort in Amsterdam. Karin
Britsemmer, Jennie Ursum and Dirkjan van Schaardenburg, Jan
van Breemen Institute Amsterdam.
86. WITHDRAWN
87. The Impact of Health Beliefs on Therapeutic Adherence in
Patients with Rheumatoid Arthritis (RA). Tara J. Rizvi 1 , John
Gomez 1 , Sofia de Achaval 2 , Michael A. Kallen 2 , Vanessa L. Cox 2 ,
Marsha N. Richardson 2 , Bernard Ng 1 , John D. Reveille 3 and
Maria E. Suarez-Almazor 4 , 1 Baylor College of Medicine, Houston,
TX, 2 The University of Texas M. D. Anderson Cancer Center,
Houston, TX, 3 Univ Texas Health Sci Ctr, Houston, TX, 4 University
of Texas, MD Anderson Cancer Center, Houston, TX.
88. TNF and Natural Atheroprotective Antibodies Against
Phosphorylcholine: Implications for Biologics in RA. Sofia
Ajeganova, Roland Fiskesund, Ingiäld Hafström and Johan
Frostegård, Karolinska Institutet, Sweden.
89. TNF Therapy Reduces the Odds of Worsening Disability
Trajectories in Rheumatoid Arthritis over at Least 2 Years –
Data from the NDB-Portugal Cohort. Sofia Pedro 1 , Elizabeth
Benito-Garcia 1 , Joana Vasconcelos 1 , Irina Chaves 1 , Rita
Marques 1 , Andreia Rodrigues 1 , Kaleb Michaud 3 and Fred Wolfe 2 ,
1
Bioepi Clinical and Translational Research Center, Oeiras,
Portugal, 2 National Databank for Rheumatic Diseases, Kansas,
3
University of Nebraska Medical Center, NE.
90. TNF-alpha Blocking Therapy Lowers Cardiovascular Risk in
Rheumatoid Arthritis. Ingrid M. Visman 1 , Alper M. van Sijl 3 ,
Mike J. L. Peters 5 , Carlo J. J. van Dongen 1 , Ben A. C. Dijkmans 4
and Michael T. Nurmohamed 2 , 1 Jan van Breemen Institute, 2 Jan
van Breemen Institute and VU Medical Centre, Amsterdam,
The Netherlands, 3 Jan van Breemen Institute and VU Medical
Centre, 4 VU Medical Centre, Amsterdam, The Netherlands, 5 VU
Medical Centre.
91. Validation of the Work Performance Visual Analog Scale:
Measuring Work and Household Productivity of Patients with
Early, Aggressive Rheumatoid Arthritis. Dennis Revicki 2 , Sanjoy
Roy 1 , Miriam Kimel 2 , Chris Thompson 2 and Mary Cifaldi 1 , 1 Abbott
Laboratories, Abbott Park, IL, 2 United Biosource Corporation,
Bethesda, MD.
Fibromyalgia and Soft Tissue Disorders I
92. Candidate Gene Studies of Fibromyalgia: A Systematic Review
and Meta-Analysis. Young Ho Lee, Sung Jae Choi, Jong Dae Ji
and Gwan Gyu Song, KUMC, Seoul, Korea, Republic of.
93. Clinical Determinants of Physical Activity in Fibromyalgia
Patients. Dennis Ang 1 , Anthony Kaleth 3 , Silvia Bigatti 2 , Steven
Mazzuca 2 , Chandan Saha 2 and Robert Bandy 2 , 1 Indiana
University, Indianapolis, IN, 2 Indiana University, 3 Indiana
University-Purdue University Indianapolis.
94. Development of Responder Definitions for Fibromyalgia
Clinical Trials. Lesley M. Arnold 8 , Philip J. Mease 6 , David A.
Williams 7 , Susan A. Martin 5 , Fujun Wang 2 , Birol Emir 4 , Chinglin
Lai 3 and Rong Zablocki 1 , 1 Cypress Bioscience, Inc., 2 Eli Lilly
and Company, 3 Jazz Pharmaceuticals, 4 Pfizer, Inc., 5 RTI-Health
Solutions, 6 Seattle Rheumatology Associate, Seattle, WA, 7 Univ
of MI Hlth System-Lobby M, Ann Arbor, MI, 8 University of
Cincinnati College of Medicine, Cincinnati, OH.
95. Does Obesity in Patients with Fibromyalgia Modify Response
to Tai Chi Therapy: Analysis of a Randomized Controlled Trial.
Chenchen Wang 1 , Christopher H. Schmid 2 , Yoojin Lee 2 and
Timothy McAlindon 1 , 1 Tufts Medical Center, Boston, MA, 2 Tufts
Medical Center.
96. Dorsal Root Ganglia/Sympathetic Ganglia Sodium Channels
Gene Polymorphisms in Fibromyalgia. Gilberto Vargas-Alarcon,
Edith Alvarez-Leon, Jose-Manuel Fragoso, Angelica Vargas, Aline
Martinez, Maite Vallejo and Manuel Martinez-Lavin, National
Institute of Cardiology, Mexico.
97. Durability of Response in a 38-Week Open-Label Study of
Sodium Oxybate in Patients with Fibromyalgia. Michael
Spaeth 5 , I. Jon Russell 7 , Serge Perrot 6 , Sarah Alvarez-Horine 3 ,
Diane R. Guinta 1 , Y. Grace Wang 2 and Robert M. Bennett 4 , 1 Jazz
Pharmaceuticals Inc., Palo Alto, CA, 2 Jazz Pharmaceuticals Inc.,
3
Jazz Pharmaceuticals, Inc., 4 Oregon Health and Science Univ,
Portland, OR, 5 Rheumatologische Schwerpunktpraxis, 6 Service
de Medecine Interne et Centre de la Douleur, Hôtel-Dieu,
7
University of Texas Health Science Center, San Antonio, TX.
98. Effects of Milnacipran Added to Pregabalin on Cognition and
Mental Clarity in Fibromyalgia Patients. Robert S. Katz 4 , Robert
H. Palmer 2 , Yong Wang 3 and R. Michael Gendreau 1 , 1 Cypress
Bioscience, Inc, San Diego, CA, 2 Forest Research Institute, Jersey
City, NJ, 3 Forest Research Institute, 4 Rush University Medical
Center, Chicago, IL.
99. Fatigue in Fibromyalgia Patients: A Qualitative Study Exploring
a Conceptual Framework. Philip J. Mease 4 , Lisa D’Ambrosio 3 ,
Asha Hareendran 6 , Maureen Mohyde 2 , Robin Pokrzywinski 6 ,
Kristin Seymour 5 and Steven Blum 1 , 1 Forest Research Institute,
2
Outcome Sciences, 3 Outcome Sciences and MIT AgeLab,
4
Seattle Rheumatology Associate, Seattle, WA, 5 Seattle
Rheumatology Associates, 6 United BioSource Corporation.
100. Fibromyalgia Criteria and Severity Scales for Clinical and
Epidemiological Studies: A Modification of the ACR Preliminary
Diagnostic Criteria for Fibromyalgia. Frederick Wolfe 2 , Daniel
J. Clauw 7 , Mary Ann Fitzcharles 1 , Don L. Goldenberg 3 , Winfried
Häuser 6 , Robert S. Katz 4 , Philip J. Mease 5 , Anthony S. Russell 8 ,
I. Jon Russell 10 and John B. Winfield 9 , 1 Montreal West, QC,
Canada, 2 National Data Bank for Rheumatic Diseases, Wichita,
KS, 3 Newton-Wellesley Hosp, Newton, MA, 4 Rheumatology
Associates, Chicago, IL, 5 Seattle Rheumatology Associate,
Seattle, WA, 6 Technische Universität München, Munich,
Germany, 7 UM/Chronic Pain & Fatigue Res, Ann Arbor, MI,
8
University of Alberta, Edmonton, AB, Canada, 9 University of
North Carolina, Chapel Hill, NC, 10 University of Texas HSC, San
Antonio, TX.
2010 Program Book 153